The electronic nose as a diagnostic tool in the discrimination of COPD and controls

Completed

• Conditions: COPD, Asthma, wheezing, airway inflammation, smoking

• Registration Number: NL-OMON23287
• Lead Sponsor: Academic Medical Center Amsterdam, The Netherlands

Brief Summary

N. Fens, MD1, M.P.C. van der Schee, BSc1, D. Cheung, MD,PhD2, E. Dijkers1, S.B. de Nijs1, P.J.E. Bindels, MD,PhD1, E.H.D. Bel, MD,PhD1 and P.J. Sterk, MD,PhD1. 1Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands and 2Vlietland Hospital, Schiedam, Netherlands. COPD can be Discriminated from Controls by Fingerprint Analysis of Volatile Organic Compounds in Exhaled Air using eNose Technology. Abstract ATS 2008.<br> - N. Fens, N.Fens@amc.nl, MD1, M.P.C. van der Schee, M.P.C.van_der_Schee@lumc.nl1, S.B. de Nijs, S.B.deNijs@amc.nl1, E. Dijkers, E.Dijkers@amc.nl1, Prof. Dr E.H. Bel, E.H.Bel@amc.nl, MD1 and Prof. Dr P.J. Sterk, P.J.Sterk@amc.nl, MD1. 1Respiratory Medicine, Academic Medical Center, Amsterdam, Netherlands. Exhaled breath molecular profiling in measuring inflammatory status in COPD http://www.ncbi.nlm.nih.gov/pubmed/19713445?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 120

Inclusion Criteria

1. COPD patients

2. A minimum of ten patients 40-75 years with moderate to severe COPD:

Exclusion Criteria

Two or more of the following:

•Severe cardiovascular disease, history or present

Study & Design

• Study Type: Interventional
• Study Design: Not specified